A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
Status:
Completed
Trial end date:
2019-09-26
Target enrollment:
Participant gender:
Summary
This is a preoperative window, phase 0 study of short-term atorvastatin treatment in obese
women who are to undergo surgical staging for endometrial cancer.
Phase:
Early Phase 1
Details
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborator:
Wilma Williams Education and Clinical Research for Endometrial Cancer Award